Mortality at day 30 · AKI
Intensive showed no clear difference in mortality at day 30 compared with less intensive continuous renal replacement therapy (CRRT) (low certainty).
1 finding from 1 review
Mortality: patients with sepsis · patients with AKI who need CRRT
Intensive showed no clear difference in mortality: patients with sepsis compared with less intensive continuous renal replacement therapy (CRRT) (low certainty).
1 finding from 1 review
Mortality: patients without sepsis · patients with AKI who need CRRT
Intensive showed no clear difference in mortality: patients without sepsis compared with less intensive continuous renal replacement therapy (CRRT) (low certainty).
1 finding from 1 review
Mortality after 30 days post‐randomisation · AKI
Intensive showed no clear difference in mortality after 30 days post‐randomisation compared with less intensive continuous renal replacement therapy (CRRT) (low certainty).
1 finding from 1 review
Mortality: patients with AKI not related to surgery · patients with AKI who need CRRT
Intensive showed no clear difference in mortality: patients with AKI not related to surgery compared with less intensive continuous renal replacement therapy (CRRT) (low certainty).
1 finding from 1 review
Mortality: patients with AKI related to cardiac or general surgery · patients with AKI who need CRRT
Intensive leads to lower mortality: patients with AKI related to cardiac or general surgery compared with less intensive continuous renal replacement therapy (CRRT) (high certainty).
1 finding from 1 review
All‐cause mortality · persons with type 1 diabetes mellitus
Intensive glucose control showed no clear difference in all‐cause mortality compared with conventional glucose control (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with type 2 diabetes mellitus
Intensive glycaemic control showed no clear difference in mortality compared with standard glycaemic control (moderate certainty).
Cardiovascular mortality · patients with type 2 diabetes mellitus
Intensive glycaemic control showed no clear difference in cardiovascular mortality compared with conventional glycaemic control (moderate certainty).
1 finding from 1 review
All‐cause mortality · people at increased risk for developing type 2 diabetes
1 finding from 1 review
Cardiovascular mortality · people at increased risk for developing type 2 diabetes
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Perinatal mortality · women in established labour and their babies.
It is very uncertain whether intermittent ausculation of fetal heart rate in labour for fetal… changes perinatal mortality compared with routine Pinard (outcomes (very low certainty).
1 finding from 1 review
Adverse events—all‐cause mortality · type 1 or type 2 diabetics
1 finding from 1 review
no estimate extracted
1 participants
GRADE not reported
Death or serious morbidity composite · women in established labour and their babies.
1 finding from 1 review